Skip to content

Nuvation Bio NUVB Interest Expense

Interest Expense at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M+200%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$13.87M+2.5%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$10K-75.0%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$39.9M+25.7%
Incyte logo
IncyteINCY
$569K-13.8%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's interest expense?
Nuvation Bio (NUVB) reported interest expense of $6.71M in Q1 2026.
How has Nuvation Bio's interest expense changed year-over-year?
Nuvation Bio's interest expense increased by 12322.2% year-over-year, from $54K to $6.71M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.